VENICE, ITALY, 25 -27 September 2016 – NeoAsia (M) Sdn Bhd, a regional distributor of skincare, medical aesthetic equipment and medical device products in collaboration with RegenLab has participated in the 9th Biobridge Foundation Conference with at least 500 doctors participating in this annual conference. The BioBridge Foundation was created in Switzerland with the objective of promoting scientific research in Regenerative Medicine, in particular cell therapies.
Regen Lab is a global leader in products for autologous regenerative medicine based on freshly prepared platelet rich plasma (platelet concentrate or PRP) from the patient’s own blood, used either alone or combination with hyaluronic acid or other fresh autologous cells from the patient’s fat or bone marrow.
These freshly prepared concentrates are safer and have longer lasting effects than traditional cell-therapy products, they accelerate healing and have proven efficacy in ageing management, wound care and musculoskeletal pathologies.
A group of doctors from Malaysia that participated in Biobridge 2016 with NeoAsia (M) Sdn Bhd
From Left to Right: Dr Douglas Yuen, Dr Lim Ting Song, Dr Alice Prethima, Dr Melissa Liaw and Dr Jasmine Ruth.
Doctors having a fun time in Venice.
From Left to Right: Dr Douglas Yuen, Mr Jimmy Ang, MD of NeoAsia, Dr Lim Ting Song, Dr Kee Yong Seng, Mr Chen Heng Hui, Strategic Manager of NeoAsia, Dr Alice Prethima and Dr Jasmine Ruth.